Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT for Cancer Screening in High-Risk Unprovoked VTE
NCT03937583Phase 4Unknown
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fludeoxyglucose f 18 in cancer (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Number of neoplasms diagnosed using extended screening at 3 years. Status: unknown.
02
Drugs
fludeoxyglucose f 18
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03937583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937583.